O’Ryan.Health, a leader in at-home pediatric healthcare innovation, today announced it has become the first US company to launch two, parent-led observational studies “The Healthy Kids Study” and “The JDM Study,” involving the in-home collection of pediatric blood from children. Juvenile Dermatomyositis (JDM) is an ultra-rare pediatric autoimmune disorder. These studies, made possible through a partnership with YourBio Health, a pioneer in capillary blood sampling, allow parents to safely and efficiently sample their children’s blood without having to travel to a medical facility.
Artificial Intelligence is no longer a future concept in healthcare — it is already reshaping how clinicians work, how patients are treated, and how health systems operate under pressure.
But while the excitement around AI continues to grow, the real…
For decades, hospitals were designed around buildings, departments, and paper-based processes.
But healthcare is changing rapidly.
Rising patient demand, workforce shortages, digital transformation, and the shift toward preventative and community-based care are forcing healthcare leaders to rethink what a hospital…